SAN DIEGO--(BUSINESS WIRE)--A half-day session, on the application of the principals of personalized medicine to the development of improved treatments for central nervous system disorders, chaired by Larry Alphs, MD, PhD, Medical Affairs Johnson and Johnson and George Garibaldi, M.D., Clinical Development, Roche Pharmaceuticals was held on 6 October 2009, at the Autumn Meeting of the International Society for CNS Clinical Trials and Methodology (ISCTM) in San Diego, CA.
